🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.80
-0.09 (-0.60%)
Nov 20, 2026, 12:03 PM EST - Market open

Aurinia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
314.27287.25.75-78.02-108.18-180.97
Depreciation & Amortization
19.3619.4519.4511.652.712.76
Loss (Gain) From Sale of Investments
-8.48-10.18-12.73-12.14-1.570.66
Stock-Based Compensation
14.8314.6831.645.3132.331.24
Other Operating Activities
-156.31-166.71-5.125.352.0310.24
Change in Accounts Receivable
-16.69-4.91-12.46-10.611.93-15.42
Change in Inventory
1.07-6.460.48-15.87-9.07-5.64
Change in Accounts Payable
-1.07-1.870.861.24-0.794.08
Change in Unearned Revenue
0.723.675.793.763.05-
Change in Other Net Operating Assets
9.480.810.7815.86-1.93-4.65
Operating Cash Flow
177.16135.6644.39-33.46-79.53-157.69
Operating Cash Flow Growth
47.51%205.62%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.14-0.25-0.28-0.72-0.29-0.3
Sale (Purchase) of Intangibles
------1.2
Investment in Securities
-154.2-32.5239.595.88-59.68-84.53
Other Investing Activities
---0.04-11.86-0.66-17.84
Investing Cash Flow
-149.12-32.7739.26-6.71-60.63-103.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--13.14-11.99-10.03--
Net Debt Issued (Repaid)
-14.39-13.14-11.99-10.03--
Issuance of Common Stock
71.8814.959.277.173.47221.11
Repurchase of Common Stock
-108.88-107.92-46.37-2.28-1.04-
Other Financing Activities
-3.7-----
Financing Cash Flow
-55.09-106.11-49.09-5.132.43221.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-27.04-3.2234.56-45.3-137.73-40.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
177.03135.4144.11-34.18-79.82-158
Free Cash Flow Growth
47.96%206.99%----
Free Cash Flow Margin
55.02%47.84%18.76%-19.47%-59.55%-346.44%
Free Cash Flow Per Share
1.300.980.30-0.24-0.56-1.22
Levered Free Cash Flow
140.4891.4162.94-3.89-35.1-98.48
Unlevered Free Cash Flow
142.994.1265.96-2.16-35.1-98.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
2.082.822.180.51.980.26
Change in Working Capital
-6.5-8.785.45-5.61-6.82-21.63
SEC Filings: 10-K · 10-Q